Peptides Archives

TIDES Conference – Recap of Sessions

By Mrinmoy Nag May 19, 2026 Advanced Therapies Biologics Peptides

I had the privilege of attending the TIDES conference in Boston from May 12th to 14th. TIDES is always a standout event where attendees can hear about the latest advances in oligonucleotide and peptide therapeutics, along with valuable insights into the evolving landscape of drug development and manufacturing. This year was no exception, with a strong […]

May

While Not Entirely New – Guidance Places Stamp of Approval on Some Synthetic Peptides Where the RLD is of rDNA Origin

By Bob Pollock May 20, 2021 ANDAs FDA Generics Peptides Regulatory Affairs

For the last 5 or so years, the FDA has told applicants that they could likely submit an ANDA for a synthetic peptide product (40 amino acid chains or fewer) when the reference listed drug (RLD) was of rDNA origin but the guidance on which products, how, and what would be required was often sketchy. […]